Home Treatment With Carfilzomib in Patients With Multiple Myeloma

Clinical trial NCT05620238 · COMPLETED

Trial details

NCT number: NCT05620238
Sponsor: Thomas Lund
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2022-12-15
Primary completion: 2026-02-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.